LightReader

Chapter 899 - Chapter 532: One More Shot

Changqing Biological, Core Laboratory.

"The patient's treatment eligibility assessment is complete."

"The isolation and purification of T-cells from serum samples are complete."

"The antigen virus vector has been successfully introduced, and the T-cells have shown good chimerism with the antigen receptor."

"Group 2, numbers 21 and backup 23 chimeric T-cells have been transferred to an in vitro culture dish for Car-T cell expansion..."

Listening to his subordinate researchers report the progress of their work one by one, Zheng Dalu looked at the pale yellow culture fluid in the glass dish, his expression filled with excitement.

Car-T therapy was naturally not unfamiliar to Zheng Dalu.

After all, his main focus during his time at medical school was genetic engineering technology.

Using a virus as a transport vector, gene fragments obtained through genetic engineering editing serve as chimeras to activate human T-cells to target and eliminate specific cancer cells precisely.

This is the end of Part One, download Chereads app to continue:
More Chapters